Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 7 of 7 citing Takami: Effects of dietary treatment alone or diet with voglibose or glyburide on abdominal.... (0.08 sec) 

α-Glucosidase inhibitors for patients with type 2 diabetes


FA van de Laar, PL Lucassen, RP Akkermans, EH … - Diabetes Care, 2005 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—We systematically searched the Cochrane Central register of Controlled
Trials, MEDLINE, EMBASE, Current Contents, LILACS, databases of ongoing trials, and reference lists,
and we contacted experts and ...
Cited by 80 - Related articles - All 7 versions

Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type …


T Nakamura, T Matsuda, Y Kawagoe, H Ogawa, Y … - Metabolism, 2004 - Elsevier
Atherosclerosis is the major cause of morbidity and mortality in patients with type 2 diabetes, and
pioglitazone has been reported to have anti-inflammatory and potential antiatherogenic effects. The
aim of the present study was to ...
Cited by 75 - Related articles - All 8 versions

Combination therapy with rosiglitazone and glibenclamide compared with upward …


Z Kerenyi, H Samer, R James, Y Yan, M Stewart - Diabetes research and clinical …, 2004 - Elsevier
Aim: To compare the efficacy of combination therapy using rosiglitazone (8 mg per day) and
glibenclamide (7.5 mg per day) with upward titration of glibenclamide as monotherapy (maximum
dose=15 mg per day) in reducing HbA ...
Cited by 50 - Related articles - All 8 versions

[PDF] Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: …


ES Freedland - Nutr Metab, 2004 - biomedcentral.com
Abstract There are likely many scenarios and pathways that can lead to metabolic syndrome. This
paper reviews mechanisms by which the accumulation of visceral adipose tissue (VAT) may contribute
to the metabolic syndrome, and ...
Cited by 36 - Related articles - View as HTML - All 14 versions

Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations …


T Nakamura, T Sugaya, Y Kawagoe, Y Ueda, … - Diabetes/Metabolism … - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets. In
this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the ...
Cited by 13 - Related articles - BL Direct - All 3 versions

[PDF] Results from a Cochrane systematic review and meta-analysis


PL Lucassen, RP Akkermans, GE Rutten, C VAN … - Diabetes Care, 2005 - Am Diabetes Assoc
Results from a Cochrane systematic review and meta-analysis ... F LORIS A. VAN DE L AAR , MD 1 P
ETER L. L UCASSEN , MD, PHD 1 R EINIER P. A KKERMANS , MSC 1 ... E LOY H. VAN DE L ISDONK , MD, PHD
1 G UY E. R UTTEN , MD, PHD 2 C ...
Related articles - All 2 versions

α-葡萄糖苷酶抑制剂治疗 2 型糖尿病的系统评价


P Lucassen, RP Akkermans, EH Van de Lisdonk, G … - 中国循证医学杂志, 2006 - cqvip.com
首页; 期刊导航; 知识社区; 学者空间; 学术机构; 专题导读; 充值中心; 论文翻译. 登录 注册 帮助. 维普资讯
中文期刊·专业文章. 维普专业检索Google学术. 临床医学 >> 中国循证医学杂志 >> 2006年6卷5期 >> 摘要. ...
Related articles


 


Go to Google Home - About Google - About Google Scholar

©2009 Google